Pyrrolidine derived beta 3 adrenergic receptor agonists
US8354403B2 · kind B2 · utility
12Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 17, 2010 |
| Grant date | Jan 15, 2013 |
| Priority date | — |
| Expiry date | Aug 17, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/20
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.